BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2931141)

  • 1. [Nature of the chalone fraction of erythrocyte extracts].
    Neustroev GV
    Biull Eksp Biol Med; 1985 Sep; 100(9):339-40. PubMed ID: 2931141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erythrocytic chalone and antichalone in erythremia and symptomatic erythrocytosis].
    Bala IuM; Beloshevskiĭ VA
    Gematol Transfuziol; 1986 Jun; 31(6):6-9. PubMed ID: 2942441
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of erythrocyte chalone in regulating erythropoiesis].
    Neustroev GV
    Usp Fiziol Nauk; 1981; 12(2):131-48. PubMed ID: 6267838
    [No Abstract]   [Full Text] [Related]  

  • 4. [Superficial origin of erythrocytic chalone in polycythemia in vitro].
    Neustroev GV; Korolev NP
    Biull Eksp Biol Med; 1979 Sep; 88(9):345-8. PubMed ID: 160256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chalone-antichalone system in hematopoietic disorders].
    Bala IuM; Lifshits VM; Sidel'nikova VI
    Gematol Transfuziol; 1985 Sep; 30(9):18-20. PubMed ID: 2932361
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chalone content of the blood of polycythemia vera patients following bloodletting].
    Neustroev GV; Melikian AL; Kovaleva LG; Blazhko OB
    Gematol Transfuziol; 1986 Jun; 31(6):3-6. PubMed ID: 2942440
    [No Abstract]   [Full Text] [Related]  

  • 7. [Levels of erythrocytic inhibitors (chalones) of the blood in patients with erythropoietic disorders].
    Neustroev GV; Pomerantsev VP; Gorokhovskaia GN; Fedorova EI; Esipenko SA
    Ter Arkh; 1986; 58(9):110-2. PubMed ID: 2947342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological activity of erythrocytic chalone in erythremia].
    Neustroev GV; Petrov KIa
    Probl Gematol Pereliv Krovi; 1979 Mar; 24(3):57-8. PubMed ID: 155249
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of plasma and erythrocyte factors regulating erythropoiesis in different experimental states].
    Volzhskaia AM
    Fiziol Zh SSSR Im I M Sechenova; 1977 Nov; 63(11):1558-60. PubMed ID: 590570
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythrocytic chalone, a tissue-specific inhibitor of cell proliferation in the erythron.
    Kivilaakso E; Rytömaa T
    Cell Tissue Kinet; 1971 Jan; 4(1):1-9. PubMed ID: 4256041
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of the sympathetic nervous system in regulating the production of erythrocytic chalone].
    Mikhaĭlov Vv; Neustroev GV; Gerina LS
    Fiziol Zh SSSR Im I M Sechenova; 1980 Sep; 66(9):1344-9. PubMed ID: 6448171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of purified erythrocyte chalone on proliferating cells of the mouse erythron].
    Neustroev GV
    Fiziol Zh SSSR Im I M Sechenova; 1980 Jun; 66(6):846-51. PubMed ID: 6249649
    [No Abstract]   [Full Text] [Related]  

  • 13. [Physiological methods of treatment of patients with polycythemia vera].
    Neustroev GV
    Ter Arkh; 1985; 57(7):54-9. PubMed ID: 2931850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plasma erythropoietic-stimulating factor in man; observations on patients with polycythemia vera and secondary polycythemia.
    BETHELL FH; LINMAN JW
    J Lab Clin Med; 1957 Jan; 49(1):113-27. PubMed ID: 13385582
    [No Abstract]   [Full Text] [Related]  

  • 15. [Attempt at an experimental validation of chalone treatment of erythremia].
    Neustroev GV
    Probl Gematol Pereliv Krovi; 1981 Feb; 26(2):28-32. PubMed ID: 6453337
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sources and nature of the erythrocyte inhibitor in "in vitro polycythemia"].
    Neustroev GV
    Patol Fiziol Eksp Ter; 1979; (4):54-7. PubMed ID: 481921
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunological analysis of the content of erythrocyte chalone factors in the blood in certain types of pathology].
    Neustroev GV; Melikian AL; Kovaleva LG; Blazhko OB
    Gematol Transfuziol; 1985 Sep; 30(9):21-6. PubMed ID: 2932362
    [No Abstract]   [Full Text] [Related]  

  • 18. [Polycythemia vera and 2,3-diphosphoglycerate deficiency. Apropos of 2 cases].
    Aubert I; Aubert L; Quilichini R; Vanuxem D; Carcassonne Y
    Sem Hop; 1983 Oct; 59(39):2709-11. PubMed ID: 6316526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolism of erythrocyte chalone in vitro].
    Neustroev GV
    Biull Eksp Biol Med; 1981 Jun; 91(6):743-5. PubMed ID: 6268227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erythron in patients with polycythemia vera during treatment by erythrocytapheresis and bloodletting].
    Gudim VI; Sarycheva TG; Kotel'nikov VM; Melikian AL; Ivanova VS
    Ter Arkh; 1987; 59(6):48-51. PubMed ID: 3629498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.